The Antibody Society's antibody validation webinar series
- PMID: 32748696
- PMCID: PMC7531563
- DOI: 10.1080/19420862.2020.1794421
The Antibody Society's antibody validation webinar series
Abstract
In the wake of the reproducibility crisis and numerous discussions on how commercially available antibodies as research tool contribute to it, The Antibody Society developed a series of 10 webinars to address the issues involved. The webinars were delivered by speakers with both academic and commercial backgrounds. This report highlights the problems, and offers solutions to help the scientific community appropriately identify the right antibodies and to validate them for their research and development projects. Despite the various solutions proposed here, they must be applied on a case-by-case basis. Each antibody must be verified based on the content of the product sheet, and subsequently through experimentation to confirm integrity, specificity and selectivity. Verification needs to focus on the precise application and tissue/cell type for which the antibody will be used, and all verification data must be reported openly. The various approaches discussed here all have caveats, so a combination of solutions must be considered.
Keywords: Antibody specificity; antibody selectivity; antibody validation; monoclonal antibodies; peptide antibodies; polyclonal antibodies; recombinant antibodies; reproducibility; selective antibodies; specific antibodies.
Similar articles
-
Antibody Engineering & Therapeutics 2016: The Antibody Society's annual meeting, December 11-15, 2016, San Diego, CA.MAbs. 2016 Nov/Dec;8(8):1425-1434. doi: 10.1080/19420862.2016.1227665. Epub 2016 Aug 24. MAbs. 2016. PMID: 27557809 Free PMC article.
-
Antibody Engineering & Therapeutics 2015: The Antibody Society's annual meeting December 7-10, 2015, San Diego, CA.MAbs. 2015;7(6):981-8. doi: 10.1080/19420862.2015.1089707. Epub 2015 Sep 30. MAbs. 2015. PMID: 26421752 Free PMC article.
-
Antibody Engineering & Therapeutics, the annual meeting of The Antibody Society December 7-10, 2015, San Diego, CA, USA.MAbs. 2016;8(3):617-52. doi: 10.1080/19420862.2016.1153211. MAbs. 2016. PMID: 26909869 Free PMC article.
-
Antibodies That Work Again and Again and Again.Methods Mol Biol. 2017;1554:41-59. doi: 10.1007/978-1-4939-6759-9_2. Methods Mol Biol. 2017. PMID: 28185182 Review.
-
The current status and prospects of antibody engineering for therapeutic use: focus on glycoengineering technology.J Pharm Sci. 2015 Mar;104(3):930-41. doi: 10.1002/jps.24316. Epub 2015 Jan 12. J Pharm Sci. 2015. PMID: 25583555 Review.
Cited by
-
Misidentified biomedical resources: Journal guidelines are not a quick fix.Int J Cancer. 2022 Apr 15;150(8):1233-1243. doi: 10.1002/ijc.33882. Epub 2021 Dec 7. Int J Cancer. 2022. PMID: 34807460 Free PMC article.
-
NAb-seq: an accurate, rapid, and cost-effective method for antibody long-read sequencing in hybridoma cell lines and single B cells.MAbs. 2022 Jan-Dec;14(1):2106621. doi: 10.1080/19420862.2022.2106621. MAbs. 2022. PMID: 35965451 Free PMC article.
-
Improving the integrity and reproducibility of research that uses antibodies: a technical, data sharing, behavioral and policy challenge.MAbs. 2024 Jan-Dec;16(1):2323706. doi: 10.1080/19420862.2024.2323706. Epub 2024 Mar 6. MAbs. 2024. PMID: 38444344 Free PMC article.
-
When antibodies mislead: the quest for validation.Nature. 2020 Sep;585(7824):313-314. doi: 10.1038/d41586-020-02549-1. Nature. 2020. PMID: 32895531 No abstract available.
-
A Unique G-Quadruplex Aptamer: A Novel Approach for Cancer Cell Recognition, Cell Membrane Visualization, and RSV Infection Detection.Int J Mol Sci. 2023 Sep 20;24(18):14344. doi: 10.3390/ijms241814344. Int J Mol Sci. 2023. PMID: 37762645 Free PMC article.